Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased dischargeArticle Published on 2020-10-012023-07-06 Journal: International Journal of Infectious Diseases [Category] SARS, [키워드] COVID-19 Cytokine release syndrome interleukin-6 inhibitors sarilumab Tocilizumab [DOI] 10.1016/j.ijid.2020.07.023 PMC 바로가기
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical OutcomesObservational Study Published on 2020-10-012023-07-06 Journal: Chest [Category] SARS, [키워드] COVID-19 Cytokine release syndrome disease severity mechanical ventilation survival Tocilizumab [DOI] 10.1016/j.chest.2020.06.006 PMC 바로가기 [Article Type] Observational Study
Appropriate use of tocilizumab in COVID-19 infectionArticle Published on 2020-10-012023-07-07 Journal: International Journal of Infectious Diseases [Category] SARS, [키워드] COVID-19 Cytokines interleukin-6 therapy Tocilizumab [DOI] 10.1016/j.ijid.2020.07.036 PMC 바로가기
Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain간 이식 환자에서 SARS-CoV-2 감염의 다양한 임상 양상 및 결과: 스페인 마드리드의 단일 센터에서 초기 경험Observational Study Published on 2020-10-012022-09-11 Journal: Transplant infectious disease : an official journa [Category] MERS, SARS, 임상, 진단, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Administered age baseline broad spectrum consequence coronavirus COVID-19 CT scan diagnosed died discharged home disease severity Drug interactions Dyspnea females Fever Follow-up Hydroxychloroquine immunomodulatory therapy Immunosuppression incidence Infection interferon liver Liver function liver transplant Lopinavir Lopinavir/ritonavir median median age modify one patient onset of symptoms outcome Outpatient Pandemics Patient patients patients with COVID-19 Pneumonia Prognosis question recipients regimen remained respiratory Ritonavir SARS-CoV-2 SARS-COV-2 infection SARS-CoV2 severe acute respiratory syndrome Coronavirus single center single-center Spain still hospitalized Symptoms therapy Tocilizumab transplantation Two patient two patients was used X-ray [DOI] 10.1111/tid.13372 PMC 바로가기 [Article Type] Observational Study
Bloodstream infections in critically ill patients with COVID-19COVID-19로 중증 환자에서의 혈류 감염Article Published on 2020-10-012023-07-11 Journal: European Journal of Clinical Investigation [Category] SARS, 폐렴구균 감염증, [키워드] BSI coronavirus COVID-19 SARS-CoV-2 steroid Tocilizumab [DOI] 10.1111/eci.13319 PMC 바로가기
Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab신장 이식 후 중증 코로나19 폐렴에서 성공적으로 회복: 면역억제제와 토실리주맙을 포함한 새로운 요법 사이의 상호작용Case Reports Published on 2020-10-012022-09-11 Journal: Transplant infectious disease : an official journa [Category] MERS, SARS, 진단, 치료제, [키워드] antiviral drug antiviral drugs Atypical clinical complication coronavirus COVID-19 Hydroxychloroquine Immunosuppressed immunosuppressed patient immunosuppressed patients Immunosuppression Interaction investigated kidney Kidney transplantation Lopinavir Lopinavir/ritonavir management pandemic Patient Ritonavir SARS-COV-2 infection severe COVID-19 Severe COVID-19 pneumonia steroid therapy Tocilizumab treated Treatment [DOI] 10.1111/tid.13334 PMC 바로가기 [Article Type] Case Reports
Off-label use of tocilizumab in patients with SARS-CoV-2 infectionSARS-CoV-2 감염 환자에서 토실리주맙의 오프라벨 사용Comment Published on 2020-10-012022-09-12 Journal: Journal of medical virology [Category] MERS, SARS, 진단, [키워드] Infection off-label use patients with SARS-CoV-2 Tocilizumab [DOI] 10.1002/jmv.25897 PMC 바로가기 [Article Type] Comment
Hematologic parameters in coronavirus infection (COVID-19) and their clinical implicationsReview Article Published on 2020-10-012022-11-01 Journal: Discoveries [Category] COVID-19, [키워드] analyzed article characterized chest pain Chinese clinical clinical feature clinical implication clinical implications Coagulation Coagulopathy Complication conducted coronavirus Coronavirus infection COVID-19 COVID-19 disease COVID-19 patient Cytokine storm D-dimer described diarrhea disease dry cough Effect enveloped RNA virus fatality Fever help hematologic hematological highlight hypercoagulability implication Infection International Interpretation Loss of Smell Novel coronavirus outbreak parameter parameters Patient Pneumonia pneumonia of unknown origin poor prognosis Potential pregnant women reported Research respiratory tract SARS-CoV-2 patient Shortness of breath the disease Thrombophilia tiredness Tocilizumab treat Treatment Wuhan [DOI] 10.15190/d.2020.14 PMC 바로가기 [Article Type] Review Article
SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region신장 이식 환자의 SARS-CoV-2 감염: 이탈리아 행진 지역의 경험Article Published on 2020-10-012022-09-11 Journal: Transplant infectious disease : an official journa [Category] MERS, SARS, 진단, 치료제, [키워드] acute respiratory syndrome Administered administration Admission affecting AKI Ancona best biochemical calcineurin caused Clinical data clinical monitoring concomitance country Critical CRRT Cytosorb D-dimer death discharged dose drop Efficacy experience hospital Hydroxychloroquine ICU Immunosuppression incidence Infection inhibitors interleukin-6 interleukin-6 receptor Intubated Italy kidney kidney transplant Laboratory low-dose Marche Mortality mTOR outcome oxygen oxygen saturation pandemic Patient patients died physician Preliminary data present Prevalence receptor antagonist reduction reported respiratory SARS-CoV-2 SARS-COV-2 infection Severe acute respiratory syndrome severity significant increase Steroids the timing Tocilizumab treated Treatment two patients virus [DOI] 10.1111/tid.13377 PMC 바로가기 [Article Type] Article
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort studyArticle Published on 2020-10-012023-07-11 Journal: EBioMedicine [Category] SARS, [키워드] anti-cytokine therapy Antibody responses COVID-19 N-IgG S-IgG SARS-CoV-2 Tocilizumab viral kinetics [DOI] 10.1016/j.ebiom.2020.102999 PMC 바로가기